[#item_full_content] The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women’s health, Dr. Staci Gruber tells GBH’s All Things Considered.  Read More  

Pot Shop News
Author: Pot Shop News